{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:29:12Z","timestamp":1783488552839,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Danish Science Foundation"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jhepr.2020.100178","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T12:03:18Z","timestamp":1599134598000},"page":"100178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1493-2303","authenticated-orcid":false,"given":"Mette","family":"Vesterhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Juul","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-8096","authenticated-orcid":false,"given":"Johannes Roksund","family":"Hov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Saffioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Manon-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Julie","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Moum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Muri","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1398-1541","authenticated-orcid":false,"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Hemming","family":"Karlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2020.100178_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis \u2013 a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhepr.2019.05.005","article-title":"New treatments\/targets for primary biliary cholangitis","volume":"1","author":"Corpechot","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2020.100178_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2015.06.008","article-title":"Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis","volume":"63","author":"de Vries","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/hep.27825","article-title":"Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis","volume":"62","author":"Vesterhus","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100178_bib7","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/liv.13402","article-title":"Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100178_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.25599","article-title":"Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100178_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","article-title":"Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis","volume":"146","author":"Corpechot","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100178_bib10","doi-asserted-by":"crossref","first-page":"e0164224","DOI":"10.1371\/journal.pone.0164224","article-title":"Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis","volume":"11","author":"Ehlken","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100178_bib11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100178_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/apt.14806","article-title":"Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis","volume":"48","author":"Nielsen","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100178_bib13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/apt.12484","article-title":"Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension","volume":"38","author":"Leeming","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100178_bib14","doi-asserted-by":"crossref","first-page":"e0137302","DOI":"10.1371\/journal.pone.0137302","article-title":"Markers of collagen remodeling detect clinically significant fibrosis in chronic hepatitis C patients","volume":"10","author":"Nielsen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100178_bib15","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/apt.13819","article-title":"Fibrosis is not just fibrosis \u2013 basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury","volume":"44","author":"Nielsen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100178_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/liv.12700","article-title":"Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"Nielsen","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100178_bib17","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1007\/s10620-015-3783-9","article-title":"Circulating elastin fragments are not affected by hepatic, renal and hemodynamic changes, but reflect survival in cirrhosis with TIPS","volume":"60","author":"Nielsen","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2020.100178_bib18","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/QAD.0000000000000388","article-title":"Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers","volume":"28","author":"Leeming","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jhepr.2020.100178_bib19","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1152\/ajpgi.00158.2018","article-title":"Assessment of liver fibrosis progression and regression by a serological collagen turnover profile","volume":"316","author":"Karsdal","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2020.100178_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100178_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A\u00a0revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jhepr.2020.100178_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100178_bib24","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhepr.2020.100178_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/00365521.2014.996590","article-title":"Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis","volume":"50","author":"Leeming","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100178_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1755-1536-6-9","article-title":"Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases","volume":"6","author":"Genovese","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.jhepr.2020.100178_bib27","doi-asserted-by":"crossref","first-page":"e84934","DOI":"10.1371\/journal.pone.0084934","article-title":"MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis \u2013 validation of two novel biomarker assays","volume":"8","author":"Sand","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100178_bib28","first-page":"403","article-title":"Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology","volume":"4","author":"Vassiliadis","year":"2012","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jhepr.2020.100178_bib29","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.clinbiochem.2010.03.012","article-title":"A\u00a0novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen","volume":"43","author":"Barascuk","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jhepr.2020.100178_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"Suppl 2","key":"10.1016\/j.jhepr.2020.100178_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/13697137.2015.1101256","article-title":"Role of biochemical markers in the management of osteoporosis","volume":"18","author":"Henriksen","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.jhepr.2020.100178_bib33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100178_bib34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.30163","article-title":"ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced gibrosis","volume":"69","author":"Daniels","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100178_bib35","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1038\/s41598-018-30457-y","article-title":"An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis","volume":"8","author":"Luo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2020.100178_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.30590","article-title":"NGM282 improves liver fibrosis and histology in 12 weeks in patients with nonalcoholic steatohepatitis","volume":"71","author":"Harrison","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100178_bib37","article-title":"Changes in serum bile acids correlate with 7alpha-hydroxy-4-cholesten-3-one and fibrogenesis biomarker PRO-C3 with NGM282 therapy in patients with nonalcoholic steatohepatitis","author":"Sanyal","year":"2019","journal-title":"EASL"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920301129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920301129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:25:43Z","timestamp":1762899943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920301129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2589555920301129"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100178","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100178"}}